Search results
Scientists discover how deadly skin cancer evades the human immune system
Medical Xpress· 1 hour agoMelanoma is notoriously difficult to treat in its advanced stages. Despite some treatments that have improved outcomes, a category of melanomas remains ...
Is that mole melanoma? How to tell if a mole is cancerous or not
TODAY via Yahoo News· 3 days agoThat's one of the reasons that May is National Skin Cancer Awareness Month. Many Americans are...
Teenage skin cancer survivor warns of sunbed risks
BBC via Yahoo News· 11 hours agoGeorgia Edwards before having surgery for her melanoma [PA] A woman from Surrey who had a melanoma as a teenager is warning people about the danger of...
Woman, 38, has 100 moles removed after melanoma diagnosis: ‘I wear my scars proudly’
Today· 3 days agoTwo months after her mom died from melanoma, Theresa Kurtz was stunned to receive her own skin...
Woman Survives Melanoma After Having 100 Abnormal Moles Removed
People via Yahoo News· 3 days agoTwo months after Theresa Kurtz's mother died of melanoma, she went to the dermatologist and was...
How new immunotherapy is helping treat advanced stage 4 melanoma
Your Hometown Lima Stations· 21 hours agoMelanoma is considered the deadliest of all skin cancers, but a new FDA-approved immunotherapy could...
Horrifying video shows how 'blemish' on nail can morph into stage 4 cancer
The US Sun· 6 days agoA HORRIFYING time-lapse video reveals how a tiny brown line on your finger can morph into stage four...
Shedding light on melanoma: What Incline Village residents need to know during Skin Cancer Awareness...
Tahoe Daily Tribune· 2 days agoWhile our region’s abundance of outdoor activities enriches our lives, it is essential to...
Iovance (IOVA) Gears Up for Q1 Earnings: Here's What to Expect
Zacks via Yahoo Finance· 3 days agoInvestors' focus will likely be on Iovance's (IOVA) progress with its ongoing commercial launch for...
Merck Reports Progress On The Cancer Front As It Prepares For Keytruda Patent Expiration
Benzinga· 7 days agoMerck reported improvement in cancer patients receiving its Keytruda regimen. Enrolling 698...